✦ LIBER ✦

Bromfenac solution enhances ranibizumab treatment of AMD

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranibizumab for the treatment of neovasc

✍ P. K. Kaiser; D. V. Do 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Preclinical aspects of anti-VEGF agents

✍ Meyer, C H; Holz, F G 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 469 KB

Comparing Treatment Patterns And Efficac

✍ Jiang, S.; Park, C.; Barner, J.C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Predictive value of VEGF A and VEGFR2 po

✍ Cruz-Gonzalez, Fernando; Cabrillo-Estévez, Lucía; López-Valverde, Gloria; Cieza- 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 264 KB

PEY3 RANIBIZUMAB (LUCENTIS®) IS A COST-E

✍ AS Neubauer; El Back; T Kuehn; VS Thomas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PSS20 COST-UTILITY ANALYSIS OF A PRN (AS

✍ K Moeremans; L Gerlier; P Mitchell; M Gallagher; G Vincze 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB